David Burke
Vice President of Investor RelationsMr. David Burke is Vice President of Investor Relations of Sernova Biotherapeutics Inc (formerly known as Sernova Corp.) from October 2024. Mr. David Burke was Director of Investor Relations at Albemarle Corporation. He served as Director, IR & Corporate Communications at Dynavax Technologies Corp. Mr. Burke served as Director of Investor Relations at Versartis, Inc. He served as Vice President of The Ruth Group, Inc. until January 23, 2017. Mr. Burke has over 9 years? experience providing senior management teams of publicly traded companies with strategic IR counsel. He has broad exposure across many industries including healthcare, technology, clean energy and industrials, among others. During his career, he has advised clients on the development of successful investor communications platforms, capital market transactions and crisis management. His experience includes counseling companies during their IPO process and implementing post-pricing marketing efforts to gain increased visibility among the investment community. Prior to joining The Ruth Group, he served as Vice President at The IGB Group where he managed the investor relations programs for companies in the US, Europe and South America with a wide range of market capitalizations. Prior to that, he was with New York-based KCSA Strategic Communications. He also held positions with Deutsche Bank Securities and Thomson Financial. He received his B.A. in Industrial Relations from the University of North Carolina at Chapel Hill.
Positions
- Company NameSernova Biotherapeutics IncStock CodeSEOVFPositionVice President of Investor RelationsColleagues
- JMJonathan M. N. RigbyPresident, CEO & Director
- JLJohn L. BrooksIndependent Chairman
- JTJames T. ParsonsChief Financial Officer
- MRMarylyn RigbyChief Communications Officer
- PBPatricia BeastonSernova Biotherapeutics Inc.
- RARobert A. GabbayChairman of Clinical Advisory Board
- NCNorman C. W. WongMember of Scientific Advisory Board
- JDJannette DufourMember of Scientific Advisory Board
